The FDA approved semaglutide under the brand name Wegovy specifically for chronic weight management in 2021
Efficacy for Weight Loss Tirzepatide is believed to be more potent than semaglutide due to its ability to target both GLP-1 and GIP
Found is not affiliated or endorsed by Novo Nordisk A/S., the owner of the registered trademarks Wegovy, Ozempic, Saxenda, and Victoza, nor is it affiliated or endorsed by Eli Lilly & Co., the owner of the registered trademarks Zepbound, Mounjaro, and Foundayo
Shes even helped me realize there are other methods to ease up my depression, other than those who would rather drug me up
Each escalation brings a temporary resurgence of GI symptoms as the body adjusts to the stronger gastric emptying delay